Immune infiltration is linked to increased transcriptional activity and distinct metabolic profiles in chordomas
Siddh van OostiD, Rick UrsemiD, Zeynep Betül ErdemiD, Sara Cardoso, Sanne VennekeriD, Ruud van der BreggeniD, Inge H. Briaire‐de BruijniD, Alwine B. KruisselbrinkiD, Wilco C. PeuliD, Károly SzuhaiiD, Robert J. P. van der WaliD, René J. M. van Zeijl, Bram HeijsiD, Noel F.C.C. de MirandaiD, Judith V.M.G. BovéeiD
Abstract
Chordomas are ultra-rare cancers from the axial skeleton with limited treatment options. Chordomas can exhibit immunogenic features, and immune checkpoint blockade has demonstrated clinical activity in some patients, yet the determinants of these responses remain poorly understood. We aimed to elucidate the biological basis of immunogenicity in chordomas through spatial transcriptomic and metabolomic analyses. We applied GeoMx digital spatial profiling to 15 chordomas, analyzing tumor and stromal compartments separately and comparing inflamed and non-inflamed tumors. Consecutive tissue sections were examined using MALDI-mass spectrometry imaging (MSI) at 20 {micro}m spatial resolution. Findings were further explored through immunohistochemistry analyses. To assess whether transcriptional activity in tumor cells was associated with interferon-{gamma} (IFN-{gamma}) signaling, we tested the effect of IFN-{gamma} treatment on chordoma cell lines. Digital spatial profiling of inflamed and non-inflamed chordomas revealed striking differences in both the cancer cell and stromal compartments. Increased immune infiltration was strongly associated with elevated transcriptional activity in cancer cells. MALDI-MSI revealed distinct metabolic signatures and pronounced glycogen accumulation in inflamed chordomas. Nevertheless, IFN-{gamma} stimulation of chordoma cell lines did not induce expression of TBXT (brachyury), the master transcriptional regulator of chordoma biology. Collectively, our findings reveal a strong association between the transcriptomic and metabolic activity in chordomas and their immunogenicity. However, the causal direction of this relationship remains to be determined. Nevertheless, these findings are highly relevant for patient stratification, particularly in the context of immunotherapeutic strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 22th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multimodal profiling of chordoma immunity reveals distinct immune contextures
S. van Oost, D. M. Meijer, … J. V. M. G. Bovee·bioRxiv·Sep 14, 2023
- Multiplexed Imaging Mass Cytometry of Chemokine Milieus in Metastatic Melanoma Characterizes Features of Response to Immunotherapy
T. Hoch, D. Schulz, … B. Bodenmiller·bioRxiv·Jul 29, 2021
- DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment
S. P. Baluszek, P. Kober, … M. P. Bujko·bioRxiv·May 6, 2023
- Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types
R. Bao, J. J. Luke·bioRxiv·Sep 18, 2019
- Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defineshyperactivated Tregs as a potential therapeutic target
G. Alvisi, A. Termanini, … A. Lleo·bioRxiv·Mar 6, 2022
- A transcriptome-wide meta-analysis reveals lack of cancer-cell intrinsic determinants of response to immune checkpoint blockade
Y. A. Guo, T. Kulshrestha, … A. Jacobsen Skanderup·bioRxiv·Jul 30, 2023